Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and approve Annual audited financial results of the Company for the year ended March 31, 2025 (both standalone & consolidated) and declaration of Interim Dividend, if any, for the FY 2024-25 and fixation of record date for determining the eligibility of shareholders.

pdf

Caplin Point Laboratories Ltd.

23 Apr 2025

2113.40

-0.13%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

pdf

Caplin Point Laboratories Ltd.

21 Apr 2025

2113.40

-0.13%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Cessation

BSE India

The details of resignation of Senior Management Personnel is attached herewith.

pdf

Caplin Point Laboratories Ltd.

03 Apr 2025

2113.40

-0.13%

Company Update

Caplin Point Laboratories Ltd - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025 is enclosed.

pdf

Caplin Point Laboratories Ltd.

02 Apr 2025

2113.40

-0.13%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Caplin Point Laboratories Limited informed that the Board of Directors of Caplin Point Far East Limited, Hong Kong, a material subsidiary of the Company had approved the investment in Neoethicals Chile SpA.

pdf

Caplin Point Laboratories Ltd.

29 Mar 2025

2113.40

-0.13%

Company Update

Caplin Point Laboratories Ltd - 524742 - Cautionary Letter From NSE And BSE On March 28, …

BSE India

Enclosing a copy of cautionary e-mail received from National Stock Exchange of India Limited and BSE Limited with respect to the intimation of Schedule of Investors/ Analyst''s Meet/ Call on August 30, 2024.

pdf